Supplemental material
Drug Delivery
Volume 25, 2018 - Issue 1
Related Research Data
The use of low molecular weight protamine chemical chimera to enhance monomeric insulin intestinal absorption
Source:
Elsevier BV
Modification of translationally controlled tumor protein-derived protein transduction domain for improved intranasal delivery of insulin
Source:
Taylor & Francis
Cell-Penetrating Peptides: Mechanisms and Applications
Source:
Bentham Science Publishers Ltd.
Analysis of Structural Requirements for the Absorption of Drugs and Macromolecules from the Nasal Cavity
Source:
Elsevier BV
Potential of Translationally Controlled Tumor Protein-Derived Protein Transduction Domains as Antigen Carriers for Nasal Vaccine Delivery
Source:
American Chemical Society (ACS)
Conjugation of Cell-Penetrating Peptides to Parathyroid Hormone Affects Its Structure, Potency, and Transepithelial Permeation
Source:
American Chemical Society (ACS)
Permeability issues in nasal drug delivery
Source:
Elsevier BV
Effect of cell-penetrating peptides on the nasal absorption of insulin
Source:
Elsevier BV
The use of cell-penetrating peptides as a tool for gene regulation
Source:
Elsevier BV
On employing a translationally controlled tumor protein-derived protein transduction domain analog for transmucosal delivery of drugs
Source:
Elsevier BV
Cell-penetrating peptides: Possible transduction mechanisms and therapeutic applications
Source:
Spandidos Publications
Absorption enhancers in nasal drug delivery: efficacy and safety
Source:
Elsevier BV
Penetratin-Mediated Transepithelial Insulin Permeation: Importance of Cationic Residues and pH for Complexation and Permeation
Source:
American Association of Pharmaceutical Scientists (AAPS)
The role of intermolecular interactions with penetratin and its analogue on the enhancement of absorption of nasal therapeutic peptides
Source:
Elsevier BV
Insulin-cell penetrating peptide hybrids with improved intestinal absorption efficiency
Source:
Elsevier BV
New strategies to improve the intranasal absorption of insulin.
Source:
Elsevier BV
A peptide carrier for the delivery of biologically active proteins into mammalian cells
Source:
Springer Nature
Modification of translationally controlled tumor protein-derived protein transduction domain for improved intranasal delivery of insulin
Source:
Taylor & Francis
Design and evaluation of variants of the protein transduction domain originated from translationally controlled tumor protein
Source:
Elsevier BV
A protein transduction domain located at the NH2-terminus of human translationally controlled tumor protein for delivery of active molecules to cells
Source:
Elsevier BV
Linking provided by
